查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1704325

2025年全球脸部注射剂市场报告

Facial Injectable Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年脸部注射剂市场规模将快速成长。到 2029 年，这一数字将成长至 226.5 亿美元，复合年增长率为 10.4%。预测期内的成长可归因于对非手术程序的需求不断增长、应用范围不断扩大、个人化和客製化、新兴市场、医疗保健趋势和生活方式的改变。预测期内的关键趋势包括对非手术程序的需求持续增长、个人化治疗方法的扩展、更加註重联合治疗以提高治疗效果、微创技术和设备的兴起以及向自然和微妙结果的转变。

人们对美容手术的兴趣日益浓厚，预计将在未来几年推动脸部注射剂市场的成长。整容手术包括旨在改善外观美感的治疗，对身体自然结构的破坏最小，通常比传统手术侵入性更小，并且通常在门诊病人进行。这种需求是由社会对外表的关注、医学进步带来的更安全、更容易获得的手术以及对自我提升和增强自信的日益增长的渴望所驱动的。脸部注射剂用于美容手术，透过精确注射肉毒桿菌毒素和真皮填充剂等物质，暂时减少皱纹，增加特定部位的体积，改善脸部轮廓。例如，2023年3月，英国美容整形外科医生协会报告称，2022年英国整容手术数量与2021年相比增长了102%，达到约31,057例。因此，对整容手术的需求不断增长，推动了脸部注射剂市场的成长。

脸部注射剂市场的主要企业正在透过长效透明质酸 (HA) 填充剂等产品进行创新，以满足对提供自然和持久效果的微创美容手术的需求。 HA 填充剂透过补充天然皮肤物质来恢復体积、抚平皱纹并改善脸部轮廓。例如，2023 年 1 月，艾尔建公司推出了 JUVEDERM VOLUX XC。这种 HA 填充剂专为 21 岁及以上患有中度至重度下颚线缺陷的人设计，用于收紧下颚线。 JUVEDERM VOLUX XC 对于寻求非手术治疗的患者来说很有吸引力，因为它可以提供自然的效果，停机时间最短，效果可持续长达 12 个月。这种填充物有研究依据，且患者满意度高，可由美容师制定个人化治疗方案。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球脸部注射剂PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球脸部注射剂市场：成长率分析
  • 全球脸部注射剂市场表现：规模与成长，2019-2024
  • 全球脸部注射剂市场预测：2024-2029 年及 2034 年规模与成长
  • 全球脸部注射剂总目标市场（TAM）

第六章市场区隔

  • 全球脸部注射剂市场：依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 肉毒桿菌毒素
  • 胶原蛋白
  • 玻尿酸
  • 羟磷石灰钙
  • 聚乳酸
  • 聚甲基丙烯酸甲酯微球（PMMA）
  • 脂肪注射
  • 其他类型
  • 全球脸部注射剂市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 减少皱纹
  • 拉皮
  • 痤疮疤痕的治疗
  • 脂肪营养障碍的治疗
  • 丰唇
  • 其他用途
  • 全球脸部注射剂市场：按最终用户、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院及门诊手术中心
  • 皮肤科和美容诊所
  • 其他最终用户
  • 全球脸部注射剂市场肉毒桿菌素细分市场、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • A 型肉毒桿菌（Botox、 Dysport、 Xeomin）
  • B型肉毒桿菌毒素（Myoblock、Neuroblock）
  • 全球脸部注射剂胶原蛋白蛋白市场细分（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 牛胶原蛋白
  • 人体胶原蛋白
  • 合成胶原胶原蛋白
  • 全球脸部注射剂市场透明质酸细分市场（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 交联玻尿酸
  • 非交联玻尿酸
  • 全球脸部注射剂市场羟基羟磷石灰钙细分市场（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • Radius（羟磷石灰钙基填料）
  • 全球脸部注射剂市场聚乳酸细分市场（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • Sculptra（聚乳酸填充剂）
  • 全球脸部注射剂市场聚甲基丙烯酸甲酯微球（PMMA）细分市场、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • Artefill（PMMA 基填充剂）
  • 全球脸部注射剂市场依脂肪注射类型、绩效及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 自体脂肪移植（抽脂和注射）
  • 脂肪移植恢復体积
  • 全球脸部注射剂市场，按类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 聚左旋乳酸
  • 聚己内酯填料
  • 其他新兴注射剂

第七章 区域和国家分析

  • 全球脸部注射剂市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球脸部注射剂市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 脸部注射剂市场：竞争格局
  • 脸部注射剂市场：公司简介
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Ipsen Pharma Overview, Products and Services, Strategy and Financial Analysis
    • Galderma SA Overview, Products and Services, Strategy and Financial Analysis
    • Merz Pharma GmbH & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Sinclair Pharma Plc
  • Revance Therapeutics Inc.
  • Suneva Medical Inc.
  • Prollenium Medical Technologies
  • SciVision Biotech Inc.
  • Anteis SA
  • Anika Therapeutics Inc.
  • Q-Med AB
  • Bloomage BioTechnology
  • Medytox Inc.
  • Teoxane Laboratories
  • Alphaeon Corporation
  • BIOPLUS CO. LTD.
  • BioPolymer GmbH & Co. KG
  • Bioxis Pharmaceuticals

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年脸部注射剂市场：提供新机会的国家
  • 2029年脸部注射剂市场：细分市场带来新机会
  • 2029年脸部注射剂市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r30186

Facial injectables are cosmetic procedures that involve injecting substances into facial tissues to enhance features, diminish wrinkles, restore volume, or enhance overall appearance without surgery. These treatments are commonly used to address aging signs or achieve specific aesthetic goals, offering results that are temporary or semi-permanent.

The primary types of facial injectables include botulinum toxin, collagen, hyaluronic acid, calcium hydroxyapatite, polylactic acid, polymethyl-methacrylate microspheres (PMMA), fat injection, and others. Botulinum toxin is a neurotoxic protein used in cosmetic procedures to temporarily relax muscle activity, primarily for reducing facial wrinkles and lines. These injectables serve various purposes such as wrinkle reduction, facelifts, acne scar treatment, lipoatrophy treatment, lip enhancement, and more. They are used by different end-users including hospitals, ambulatory surgery centers, dermatology and cosmetic clinics, among others.

The facial injectable market research report is one of a series of new reports from The Business Research Company that provides facial injectable market statistics, including facial injectable industry global market size, regional shares, competitors with a facial injectable market share, detailed facial injectable market segments, market trends and opportunities, and any further data you may need to thrive in the facial injectable industry. This facial injectable market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The facial injectable market size has grown rapidly in recent years. It will grow from $13.74 billion in 2024 to $15.22 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to the increased aging population, growth in consumer awareness, shift in beauty standards, regulatory approvals, and advancements in injection techniques.

The facial injectable market size is expected to see rapid growth in the next few years. It will grow to $22.65 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to rising demand for non-surgical procedures, expanding applications, personalization and customization, emerging markets, healthcare trends, and lifestyle changes. Major trends in the forecast period include continued growth in demand for non-surgical procedures, expansion of personalized treatment approaches, increasing focus on combination therapies for enhanced outcomes, the rise of minimally invasive techniques and devices, and a shift towards natural-looking and subtle results.

The rising interest in cosmetic procedures is expected to drive the growth of the facial injectable market in the coming years. Cosmetic procedures encompass medical treatments aimed at enhancing appearance with minimal disruption to the body's natural structure, often less invasive than traditional surgeries and typically performed on an outpatient basis. This demand is increasing due to societal focus on appearance, safer and more accessible procedures enabled by medical advancements, and a growing desire for self-improvement and confidence boost. Facial injectables are used in cosmetic procedures to temporarily reduce wrinkles, add volume to specific areas, and improve facial contours through precise injection of substances such as botulinum toxin or dermal fillers. For example, in March 2023, a report from the British Association of Aesthetic Plastic Surgeons noted a 102% increase in cosmetic procedures in the UK in 2022, reaching around 31,057 procedures, compared to 2021. Thus, the rising demand for cosmetic procedures is fueling the growth of the facial injectable market.

Leading companies in the facial injectable market are innovating with products such as long-lasting hyaluronic acid (HA) fillers to meet the demand for minimally invasive aesthetic procedures offering natural-looking and enduring results. HA fillers restore volume, smooth wrinkles, and enhance facial contours by replenishing natural skin substances. For instance, in January 2023, Allergan plc introduced JUVEDERM VOLUX XC, an HA filler specifically designed to enhance jawline definition for individuals aged 21 and above with moderate to severe contour loss. Providing effects lasting up to twelve months, JUVEDERM VOLUX XC delivers natural-looking results with minimal downtime, appealing to patients seeking non-surgical options. Supported by research and high patient satisfaction, this filler enables customized treatment plans by cosmetic specialists.

In October 2022, Prollenium Medical Technologies acquired SoftFil for an undisclosed amount, expanding its product range and enhancing its position in the aesthetic medicine industry. This acquisition strengthens innovation and offers comprehensive solutions to practitioners for optimal patient outcomes. SoftFil, a France-based company, produces cosmetic products, aesthetic microcannulas, and facial injectable solutions, complementing Prollenium's portfolio.

Major companies operating in the facial injectable market are AbbVie Inc., Sanofi S.A., Ipsen Pharma, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sinclair Pharma Plc, Revance Therapeutics Inc., Suneva Medical Inc., Prollenium Medical Technologies, SciVision Biotech Inc., Anteis S.A., Anika Therapeutics Inc., Q-Med AB, Bloomage BioTechnology, Medytox Inc., Teoxane Laboratories, Alphaeon Corporation, BIOPLUS CO. LTD., BioPolymer GmbH & Co. KG, Bioxis Pharmaceuticals, Everest Pharmaceuticals

North America was the largest region in the facial injectable market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the facial injectable market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the facial injectable market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The facial injectable market consists of sales of platelet-rich plasma (PRP) injections, collagen stimulators, lip injections, and thread lifts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Facial Injectable Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on facial injectable market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for facial injectable ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The facial injectable market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Botulinum Toxin; Collagen; Hyaluronic Acid; Calcium Hydroxyapatite; Polylactic Acid; Polymethyl-Methacrylate Microspheres (PMMA); Fat Injection; Other Types
  • 2) By Application: Wrinkle Reduction; Facelift; Acne Scar Treatment; Lipoatrophy Treatment; Lip Enhancement; Other Applications
  • 3) By End-User: Hospitals And Ambulatory Surgery Centers; Dermatology And Cosmetic Clinics; Other End-Users
  • Subsegments:
  • 1) By Botulinum Toxin: Botulinum Toxin Type A (Botox, Dysport, Xeomin); Botulinum Toxin Type B (Myobloc, Neurobloc)
  • 2) By Collagen: Bovine Collagen; Human Collagen; Synthetic Collagen
  • 3) By Hyaluronic Acid: Cross-linked Hyaluronic Acid; Non-Cross-Linked Hyaluronic Acid
  • 4) By Calcium Hydroxyapatite: Radiesse (Calcium Hydroxyapatite-Based Fillers)
  • 5) By Polylactic Acid: Sculptra (Polylactic Acid-Based Fillers)
  • 6) By Polymethyl Methacrylate Microspheres (PMMA): Artefill (PMMA-Based Fillers)
  • 7) By Fat Injection: Autologous Fat Transfer (Liposuction And Injection); Fat Grafting For Volume Restoration
  • 8) By Other Types: Poly-L-Lactic Acid; Polycaprolactone-Based Fillers; Other Emerging Injectable Fillers
  • Companies Mentioned: AbbVie Inc.; Sanofi S.A.; Ipsen Pharma; Galderma S.A.; Merz Pharma GmbH & Co. KGaA
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Facial Injectable Market Characteristics

3. Facial Injectable Market Trends And Strategies

4. Facial Injectable Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Facial Injectable Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Facial Injectable PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Facial Injectable Market Growth Rate Analysis
  • 5.4. Global Facial Injectable Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Facial Injectable Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Facial Injectable Total Addressable Market (TAM)

6. Facial Injectable Market Segmentation

  • 6.1. Global Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Botulinum Toxin
  • Collagen
  • Hyaluronic Acid
  • Calcium Hydroxyapatite
  • Polylactic Acid
  • Polymethyl-Methacrylate Microspheres (PMMA)
  • Fat Injection
  • Other Types
  • 6.2. Global Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wrinkle Reduction
  • Facelift
  • Acne Scar Treatment
  • Lipoatrophy Treatment
  • Lip Enhancement
  • Other Applications
  • 6.3. Global Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Ambulatory Surgery Centers
  • Dermatology And Cosmetic Clinics
  • Other End-Users
  • 6.4. Global Facial Injectable Market, Sub-Segmentation Of Botulinum Toxin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Botulinum Toxin Type A (Botox, Dysport, Xeomin)
  • Botulinum Toxin Type B (Myobloc, Neurobloc)
  • 6.5. Global Facial Injectable Market, Sub-Segmentation Of Collagen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bovine Collagen
  • Human Collagen
  • Synthetic Collagen
  • 6.6. Global Facial Injectable Market, Sub-Segmentation Of Hyaluronic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cross-linked Hyaluronic Acid
  • Non-Cross-Linked Hyaluronic Acid
  • 6.7. Global Facial Injectable Market, Sub-Segmentation Of Calcium Hydroxyapatite, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiesse (Calcium Hydroxyapatite-Based Fillers)
  • 6.8. Global Facial Injectable Market, Sub-Segmentation Of Polylactic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sculptra (Polylactic Acid-Based Fillers)
  • 6.9. Global Facial Injectable Market, Sub-Segmentation Of Polymethyl Methacrylate Microspheres (PMMA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Artefill (PMMA-Based Fillers)
  • 6.10. Global Facial Injectable Market, Sub-Segmentation Of Fat Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autologous Fat Transfer (Liposuction And Injection)
  • Fat Grafting For Volume Restoration
  • 6.11. Global Facial Injectable Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Poly-L-Lactic Acid
  • Polycaprolactone-Based Fillers
  • Other Emerging Injectable Fillers

7. Facial Injectable Market Regional And Country Analysis

  • 7.1. Global Facial Injectable Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Facial Injectable Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Facial Injectable Market

  • 8.1. Asia-Pacific Facial Injectable Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Facial Injectable Market

  • 9.1. China Facial Injectable Market Overview
  • 9.2. China Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Facial Injectable Market

  • 10.1. India Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Facial Injectable Market

  • 11.1. Japan Facial Injectable Market Overview
  • 11.2. Japan Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Facial Injectable Market

  • 12.1. Australia Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Facial Injectable Market

  • 13.1. Indonesia Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Facial Injectable Market

  • 14.1. South Korea Facial Injectable Market Overview
  • 14.2. South Korea Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Facial Injectable Market

  • 15.1. Western Europe Facial Injectable Market Overview
  • 15.2. Western Europe Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Facial Injectable Market

  • 16.1. UK Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Facial Injectable Market

  • 17.1. Germany Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Facial Injectable Market

  • 18.1. France Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Facial Injectable Market

  • 19.1. Italy Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Facial Injectable Market

  • 20.1. Spain Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Facial Injectable Market

  • 21.1. Eastern Europe Facial Injectable Market Overview
  • 21.2. Eastern Europe Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Facial Injectable Market

  • 22.1. Russia Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Facial Injectable Market

  • 23.1. North America Facial Injectable Market Overview
  • 23.2. North America Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Facial Injectable Market

  • 24.1. USA Facial Injectable Market Overview
  • 24.2. USA Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Facial Injectable Market

  • 25.1. Canada Facial Injectable Market Overview
  • 25.2. Canada Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Facial Injectable Market

  • 26.1. South America Facial Injectable Market Overview
  • 26.2. South America Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Facial Injectable Market

  • 27.1. Brazil Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Facial Injectable Market

  • 28.1. Middle East Facial Injectable Market Overview
  • 28.2. Middle East Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Facial Injectable Market

  • 29.1. Africa Facial Injectable Market Overview
  • 29.2. Africa Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Facial Injectable Market Competitive Landscape And Company Profiles

  • 30.1. Facial Injectable Market Competitive Landscape
  • 30.2. Facial Injectable Market Company Profiles
    • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Ipsen Pharma Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Galderma S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merz Pharma GmbH & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Facial Injectable Market Other Major And Innovative Companies

  • 31.1. Sinclair Pharma Plc
  • 31.2. Revance Therapeutics Inc.
  • 31.3. Suneva Medical Inc.
  • 31.4. Prollenium Medical Technologies
  • 31.5. SciVision Biotech Inc.
  • 31.6. Anteis S.A.
  • 31.7. Anika Therapeutics Inc.
  • 31.8. Q-Med AB
  • 31.9. Bloomage BioTechnology
  • 31.10. Medytox Inc.
  • 31.11. Teoxane Laboratories
  • 31.12. Alphaeon Corporation
  • 31.13. BIOPLUS CO. LTD.
  • 31.14. BioPolymer GmbH & Co. KG
  • 31.15. Bioxis Pharmaceuticals

32. Global Facial Injectable Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Facial Injectable Market

34. Recent Developments In The Facial Injectable Market

35. Facial Injectable Market High Potential Countries, Segments and Strategies

  • 35.1 Facial Injectable Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Facial Injectable Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Facial Injectable Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer